Qihuang Needle & Flunarizine: Effective Combo for Migraines?

Research Summary

A recent study published in Neurosciences (Riyadh) explored the effects of combining Qihuang needle (QHN) therapy with flunarizine hydrochloride (FH) for treating vestibular migraine (VM). Conducted at The First Affiliated Hospital of Guangdong Pharmaceutical University, the research involved 59 patients split between QHN+FH and FH monotherapy groups. Both groups experienced significant improvements in Dizziness Handicap Inventory (DHI) scores after 8 weeks. Notably, the QHN+FH group showed enhanced Video Head Impulse Test (v-HIT) results and lower vertigo recurrence rates at 4 weeks (14% vs. 43%) and 8 weeks (34% vs. 53%) compared to FH alone, suggesting potential benefits of the combined treatment.

Study Details

📄 Title: Impact of Qihuang needle therapy combined with flunarizine hydrochloride for vertigo in vestibular migraine.

👥 Research Team: Chen DP et al.

📚 Published In: Neurosciences (Riyadh)

📅 Publication Date: 2025 Oct

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.